Home | ClinicalTrials.gov
ClinicalTrials.gov is a website and online database of clinical research studies and information about their results
Jun 27, 2018 · The final rule for Clinical Trials Registration and Results Information Submission (42 CFR Part 11) specifies requirements for submitting clinical trial information to …
ClinicalTrials.gov PRS: Login
Welcome to the ClinicalTrials.gov Protocol Registration and Results System (PRS).
To evaluate the clinical response in Cw6-negative and Cw6-positive patients treated with secukinumab 300 mg with respect to the Psoriasis Area Severity Index (PASI) 90 response …
Statistical Analysis Plan
A RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE, THREE-ARM, PARALLEL-GROUP, PHASE 1 STUDY TO COMPARE PHARMACOKINETIC AND SAFETY OF TRS003 TO CHINA …
The risk to patients in this trial will be minimized by compliance with the eligibility criteria, close clinical monitoring and extensive guidance to the investigators, provided in the current version …
Study medication continued as long as patient was obtaining clinical benefit, or until significant toxicity, or withdrawal of consent, for up to 24 months. INX123 75.0 mg once daily on a …
Information will be provided volunteers about the clinical study and a consent shall be obtained prior to screening commencement. Participants will be screened for health conditions, their …
Overview: The Baseline Characteristics module is a tabular summary of data for each demographic and base-line measure by arm or comparison group and for the entire population …
Participant Flow Data Preparation Checklist Overview: The Participant Flow module is a tabular summary of participants’ progress through each stage of a study by assignment group. Use …